Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience

Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical TRIALs

Exact Sciences Announces Second-Quarter 2023 Results

EXACT SCIENCES EARNS 2023 GREAT PLACE TO WORK^® CERTIFICATION^™

Exact Sciences Announces First Quarter 2023 Results

Exact Sciences Extends Leadership in Colorectal Cancer Screening with New Data Presented at Digestive Disease Week^® Annual Meeting

Exact Sciences Announces Fourth Quarter 2022 Results

Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.

Exact Sciences Announces Preliminary Fourth Quarter 2022 Results

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients

Exact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS^® 2022

Exact Sciences Announces Third Quarter 2022 Results Reports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability